Pharmaceuticals News and Research

RSS

Novel antisense drug shows promise to improve health of people with NAFLD

Using a first-of-its-class drug in a clinical trial, an international research effort headed by a scientist at University of California San Diego School of Medicine reports that inhibition of a key enzyme safely and effectively improved the health of persons with non-alcoholic fatty liver disease, a chronic metabolic disorder that affects hundreds of millions of people worldwide.

16 Jun 2020

Apotex recalls some Metformin batches due to possible carcinogen

Metformin, a prescription drug for people with type II diabetes, helps maintain blood glucose levels. Apotex Inc., a Canadian pharmaceutical corporation, is voluntarily recalling some batches of its metformin drug, sold under the brand name APO-Metformin ER (extended-release).

15 Jun 2020

Antisense Therapeutics: Poster presentation on the Muscular Dystrophy Association Virtual Conference 2020 website

Antisense Therapeutics, an Australian biopharmaceutical company developing and commercializing antisense pharmaceuticals for unmet need in rare diseases announces a virtual poster presentation on the Muscular Dystrophy Association Virtual 2020 Conference website.

15 Jun 2020

Study shows how combining two drugs may be an effective treatment for HLH

Scientists at St. Jude Children's Research Hospital, UCSF Benioff Children's Hospitals and Baylor College of Medicine are investigating how to best treat hemophagocytic lymphohistiocytosis (HLH), a rare immune disorder.

12 Jun 2020

New approach prevents the foul odor of isocyanides

The suggested approach makes storage of these substances safer and more convenient while preserving key chemical properties that make isocyanides essential in many synthetic applications, such as the production of pharmaceuticals and functional materials.

12 Jun 2020

Immune modulation can cure severe and often fatal fungal infection in children

In the June 11 issue of the New England Journal of Medicine, a team of UCLA physicians and scientists describes the first case of immune modulation being used to cure a severe and often fatal fungal infection.

11 Jun 2020

NIH-funded researchers to assess drugs prescribed to treat COVID-19 in children

Researchers funded by the National Institutes of Health have launched an effort to evaluate drugs prescribed to treat COVID-19 in infants, children and adolescents across the country. The study leverages an existing clinical trial that examines drugs that are prescribed off-label to children for a variety of medical conditions.

10 Jun 2020

Role of nuclear cardiology in COVID-19

"We know that without a vaccine we're going to be dealing with this virus for a while," said Johnese Spisso, president of UCLA Health, in an interview with Johannes Czernin.

10 Jun 2020

George Mason researcher examining the use of Brilacidin for treatment of coronavirus infections

Aarthi Narayanan, Assistant Professor, National Center for Biodefense and Infectious Diseases, received $35,000 from Innovation Pharmaceuticals, Inc., for a project in which she is examining the use of Brilacidin for the treatment of coronavirus infections.

5 Jun 2020

Hesperos’ immune system-on-a-chip emulates immune reactions for tissue damage and acute inflammation

Hesperos Inc., pioneers of the Human-on-a-Chip in vitro system, today announced the publication of a new peer-reviewed publication that describes how the company’s technology can be used to investigate immune responses following treatment with biological therapeutics for multi-organ systemic diseases, including cancer, infectious diseases and inflammatory disorders.

4 Jun 2020

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

While breakthrough treatments have emerged for several cancers over the last two decades, driving striking improvements in survival and other clinical outcomes, too little is known about the risk of therapy-related hematologic cancers following targeted and immunotherapeutic approaches.

29 May 2020

A Senator from Arizona emerges as a pharma favorite

Sen. Kyrsten Sinema formed a congressional caucus to raise "awareness of the benefits of personalized medicine" in February. Soon after that, employees of pharmaceutical companies donated $35,000 to her campaign committee.

29 May 2020

Scientists from gnomAD Consortium release first set of discoveries on human genetic variation

For the last eight years, the Genome Aggregation Database Consortium (and its predecessor, the Exome Aggregation Consortium, or ExAC), has been working with geneticists around the world to compile and study more than 125,000 exomes and 15,000 whole genomes from populations around the world.

28 May 2020

Emerging antiviral may turn the tide for COVID-19 pandemic

Scientists everywhere are working overtime to develop treatments for COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.

27 May 2020

Promising researchers to receive funding through AGA Research Foundation Awards Program

The American Gastroenterological Association (AGA) is excited to announce the 17 researchers selected to receive funding through the AGA Research Foundation Awards Program.

27 May 2020

Research could help identify disturbances in the body's copper metabolism

In biology it is well-known that every living organism is triggered by the hereditary material or DNA that encodes various protein molecules, which in turn perform all the necessary biological functions and it might seem that nothing else is needed to sustain the life of an organism.

26 May 2020

Paper-based device measures lithium ion concentration in blood of bipolar disorder patients

Previous
1
...
92
93
94
95
96
97
98
...
1290
Next

Pharmaceuticals News and Research

Novel antisense drug shows promise to improve health of people with NAFLD

Apotex recalls some Metformin batches due to possible carcinogen

Antisense Therapeutics: Poster presentation on the Muscular Dystrophy Association Virtual Conference 2020 website

Study shows how combining two drugs may be an effective treatment for HLH

New approach prevents the foul odor of isocyanides

Immune modulation can cure severe and often fatal fungal infection in children

NIH-funded researchers to assess drugs prescribed to treat COVID-19 in children

Role of nuclear cardiology in COVID-19

George Mason researcher examining the use of Brilacidin for treatment of coronavirus infections

Hesperos’ immune system-on-a-chip emulates immune reactions for tissue damage and acute inflammation

Newer treatment approaches may reduce risk of therapy-related hematologic cancers

A Senator from Arizona emerges as a pharma favorite

Scientists from gnomAD Consortium release first set of discoveries on human genetic variation

Emerging antiviral may turn the tide for COVID-19 pandemic

Promising researchers to receive funding through AGA Research Foundation Awards Program

Research could help identify disturbances in the body's copper metabolism

Paper-based device measures lithium ion concentration in blood of bipolar disorder patients

Santen appoints Dr Sophia Pathai as new Vice President of Medical Affairs EMEA

Analysis: Get ready for the vaccine — they’re never simple

Durvalumab plus chemotherapy improved overall survival rate for mesothelioma patients

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring